Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 5/20 | 0.61 |
| ▸ | NR1H3 | Q13133 | 5/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | DCUN1D1 | Q96GG9 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HPGDS | O60760 | 1/20 | 0.50 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11511670 | 0.81 | ADORA3 (0.45) | NR1H2NR1H3MEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL4000432 | 0.81 | DCUN1D1 (0.45) | NR1H2NR1H3MEN1KMT2AALDH1A1 | |
| SCHEMBL1032584 | 0.81 | ROCK2 (0.45) | KDM4ELMNASMN1; SMN2MAPTHPGD | |
| SCHEMBL17214772 | 0.80 | NR1H2 (0.41) | NR1H2NR1H3MEN1KMT2AALDH1A1 | |
| Decylamine SCHEMBL11510498 | 0.80 | KDM4E (0.44) | NR1H2NR1H3MEN1KMT2AALDH1A1 | |
| SCHEMBL20528631 | 0.79 | KDM4E (0.41) | NR1H2NR1H3MEN1KMT2AALDH1A1 | |
| SCHEMBL11509840 | 0.79 | MAPT (0.46) | NR1H2NR1H3MEN1KMT2AALDH1A1 | |
| SCHEMBL532848 | 0.79 | NPC1 (0.56) | NR1H2NR1H3MEN1KMT2AALDH1A1 | |
| SCHEMBL1233176 | 0.79 | SMN1; SMN2 (0.58) | ALDH1A1CYP1A2KDM4ENPC1RAB9A | |
| SCHEMBL17205747 | 0.77 | GRK6 (0.51) | NR1H2NR1H3CYP1A2DCUN1D1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 429 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113445085-B | Acidic zinc or zinc-nickel alloy electroplating baths for depositing zinc or zinc-nickel alloy layers | 德国艾托特克公司 | 2025-05-23 | — | — | CN | claimed |
| US-11739225-B2 | Sol-gel coating compositions including corrosion inhibitor-encapsulated layered metal phosphates and related processes | THE BOEING COMPANY (US) | 2023-08-29 | — | — | US | claimed |
| EP-2703062-B1 | METHOD FOR ABSORBING ACID COMPOUNDS CONTAINED IN A GASEOUS EFFLUENT BY MEANS OF AN AMINE-BASED AQUEOUS SOLUTION | IFP ENERGIES NOW (FR) | 2022-10-12 | — | — | EP | claimed |
| US-11214882-B2 | Acidic zinc or zinc-nickel alloy electroplating bath for depositing a zinc or zinc-nickel alloy layer | ATOTECH DEUTSCHLAND GMBH (DE) | 2022-01-04 | — | — | US | claimed |
| CN-113445085-A | Acidic zinc or zinc-nickel alloy plating bath for depositing zinc or zinc-nickel alloy layers | 德国艾托特克公司 | 2021-09-28 | — | — | CN | claimed |
| US-20210246565-A1 | ACIDIC ZINC OR ZINC-NICKEL ALLOY ELECTROPLATING BATH FOR DEPOSITING A ZINC OR ZINC-NICKEL ALLOY LAYER | ATOTECH DEUTSCHLAND GMBH (DE) | 2021-08-12 | — | — | US | claimed |
| CN-112272716-B | Acidic zinc or zinc-nickel alloy plating bath for depositing zinc or zinc-nickel alloy layers | 德国艾托特克公司 | 2021-06-15 | — | — | CN | claimed |
| CN-112899736-A | PCB high-longitudinal-transverse-through-hole electro-coppering additive and preparation method thereof | 深圳中科利尔科技有限公司 | 2021-06-04 | — | — | CN | claimed |
| CN-112272716-A | Acidic zinc or zinc-nickel alloy plating bath for depositing zinc or zinc-nickel alloy layers | 德国艾托特克公司 | 2021-01-26 | — | — | CN | claimed |
| EP-3581684-B1 | AN ACIDIC ZINC OR ZINC-NICKEL ALLOY ELECTROPLATING BATH FOR DEPOSITING A ZINC OR ZINC-NICKEL ALLOY LAYER | ATOTECH DEUTSCHLAND GMBH (DE) | 2020-11-18 | — | — | EP | claimed |
| US-20080303439-A1 | Coating composition for interconnection part of electrode and plasma display panel including the same | SAMSUNG SDI CO., LTD., A CORP. OF THE REPUBLIC OF KOREA (KR) | 2008-12-11 | — | — | US | claimed |
| EP-1865963-A2 | TRIAZADIBENZOAZULENE COMPOUNDS USEFUL FOR THE TREATMENT AND PREVENTION OF PAIN AND SCREENING METHODS THEREFOR | Acadia Pharmaceuticals Inc. (US) | 2007-12-19 | — | — | EP | claimed |
| WO-2006103345-A1 | TYROSINASE INHIBITORS AND THEIR USE FOR TREATING HYPERPIGMENTARY DISORDERS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2006-10-05 | — | — | WO | claimed |
| US-20060217370-A1 | Compounds useful for the treatment and prevention of pain and screening methods therefor | ACADIA PHARMACEUTICALS INC. | 2006-09-28 | — | — | US | claimed |
| WO-2006089286-A2 | TRIAZADIBENZOAZULENE COMPOUNDS USEFUL FOR THE TREATMENT AND PREVENTION OF PAIN AND SCREENING METHODS THEREFOR COMPOUNDS USEFUL FOR THE TREATMENT AND PREVENTION OF PAIN AND SCREENING METHODS THEREFOR | ACADIA PHARMACEUTICALS INC. (US) | 2006-08-24 | — | — | WO | claimed |
| US-6515122-B1 | The invention further relates to combinatorial libraries containing two or more such compounds, as well as methods of preparing tetracyclic benzimidazole derivative compounds. | LION BIOSCIENCE AG (DE) | 2003-02-04 | — | — | US | claimed |
| EP-1218384-A4 | TETRACYCLIC BENZIMIDAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2002-11-20 | — | — | EP | claimed |
| EP-1218384-A1 | TETRACYCLIC BENZIMIDAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | LION Bioscience AG (DE) | 2002-07-03 | — | — | EP | claimed |
| WO-2001023392-A1 | TETRACYCLIC BENZIMIDAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2001-04-05 | — | — | WO | claimed |
| EP-1069211-A2 | Electroplating solutions | THE BOC GROUP, INC. (US) | 2001-01-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060217370-A1 | Compounds useful for the treatment and prevention of pain and screening methods therefor | ACHE, OPRL1, OPRK1 | NR1H2 465/4885NR1H3 590/4885MEN1 4252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.